Physician

Nathaniel Charter Cevasco, M.D.

According to 2025 Medicare claims, Nathaniel Cevasco, M.D. (NPI: 1477746881) practices dermatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is DERMATOLOGISTS OF SOUTHWESTERN OHIO, LLC. (NPI: 1801819883; TIN: 310964774) and primary practice location at 44147-4046.

Cevasco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,559 traditional Medicare patients, billed 8,743 HCPCS/CPT codes, and received $619,912 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,259 prescription claims across 599 beneficiaries totaling $695,239 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 6 records totaling $132. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $163,224 to $695,239. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,278	7,699	$489,891
2016	1,492	8,659	$663,909
2017	1,518	9,388	$695,628
2018	1,518	9,196	$659,769
2019	1,597	9,427	$669,643
2020	1,409	7,737	$536,090
2021	1,379	8,196	$581,998
2022	1,469	8,713	$570,354
2023	1,570	9,412	$641,596
2024	1,559	8,743	$619,912

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	537	1,379	$163,224
2016	536	1,314	$84,120
2017	497	1,194	$245,389
2018	496	1,206	$280,090
2019	521	1,251	$314,168
2020	539	1,238	$276,715
2021	513	1,036	$281,563
2022	522	1,169	$262,961
2023	535	1,167	$715,171
2024	599	1,259	$695,239

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	541	670	$85
17110	Destruction of skin growth, 1-14 growths	413	464	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,018	1,322	$53
17000	Destruction of precancer skin growth, 1 growth	818	1,104	$34
17003	Destruction of precancer skin growth, 2-14 growths	586	3,292	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	12	952	$255,620
Cosentyx Sensoready (2 Pens)	Secukinumab	13	364	$95,131
Dupixent Pen	Dupilumab	14	392	$52,332
Fluorouracil	Fluorouracil	82	2,276	$6,727
Ketoconazole	Ketoconazole	208	6,400	$3,819

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$132	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nathaniel Charter Cevasco, M.D.?

Tedicare shows public-source Medicare data for Nathaniel Charter Cevasco, M.D. (NPI 1477746881), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathaniel Charter Cevasco, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nathaniel Charter Cevasco, M.D.?

Nathaniel Charter Cevasco, M.D. is linked to DERMATOLOGISTS OF SOUTHWESTERN OHIO, LLC. (billing NPI 1801819883) in the available physician profile data.

Does Nathaniel Charter Cevasco, M.D. have Open Payments data?

Nathaniel Charter Cevasco, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.